• Product Name : Eszopiclone
  • Grade : IP / BP / USP
  • Therapeutic Category : Hypnotic
  • CAS No : 138729-47-2
  • COA : Available
  • MSDS : Available


Eszopiclone is slightly effective in the treatment of insomnia where difficulty in falling asleep is the primary complaint.

Specification of Eszopiclone:

Item Specification Test Results
Appearance White or almost slightly powder Complies
Identification Positive Complies
R-Enantiomer ≤0.5% 0.04%
Individual impurity ≤0.3% 0.04%
Total impurities ≤0.5% 0.05%
Residue on ignition ≤0.2% 0.06%
Heavy   Metal ≤10ppm Complies
Specific rotation +125°~+141° +138°
Loss on drying ≤0.5% 0.02%
Assay ≥98.5% 99.60%
Conclusion Meets the Requirements



Packaging details:


Packaging details: 1 kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Storage: Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat
Shelf Life: 5 years if sealed and store away from direct sun light.

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations. If you don’t mind ask with us if your nation or district isn’t recorded:

ASIA: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA: Australia, New Zealand, Fiji, and so forth.